021-51111890
购物车（）
sales@molnova.cn
PHTPP
CAS No. 805239-56-9
PHTPP ( PHTPP )
产品货号. M16016 CAS No. 805239-56-9
A potent, selective antagonist of estrogen ERβ receptor; exhibits 36-fold selective for ERβ, and is fully effective as an ERα antagonist.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥308 | 有现货 |
|
| 5MG | ￥494 | 有现货 |
|
| 10MG | ￥753 | 有现货 |
|
| 25MG | ￥1474 | 有现货 |
|
| 50MG | ￥2406 | 有现货 |
|
| 100MG | ￥3718 | 有现货 |
|
| 500MG | ￥7995 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称PHTPP
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述A potent, selective antagonist of estrogen ERβ receptor; exhibits 36-fold selective for ERβ, and is fully effective as an ERα antagonist.
-
产品描述A potent, selective antagonist of estrogen ERβ receptor; exhibits 36-fold selective for ERβ, and is fully effective as an ERα antagonist, while exhibiting no significant agonism on ERβ or Erα; enhances SKOV3 and OV2008 ovarian cancer cell growth in in vitro assays.
-
同义词PHTPP
-
通路Endocrinology/Hormones
-
靶点Estrogen Receptor/ERR
-
受体ERβ
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number805239-56-9
-
分子量423.30
-
分子式C20H11F6N3O
-
纯度>98% (HPLC)
-
溶解度DMSO: 14 mg/mL (33 mM) （ < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESOC1=CC=C(C2=C3N=C(C(F)(F)F)C=C(C(F)(F)F)N3N=C2C4=CC=CC=C4)C=C1
-
化学全称4-[2-Phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Compton DR, et al. J Med Chem. 2004 Nov 18;47(24):5872-93.
2. Chan KK, et al. J Endocrinol. 2014 May 12;221(2):325-36.
3. Kajta M, et al. Neuroscience. 2013 May 15;238:345-60.
2. Chan KK, et al. J Endocrinol. 2014 May 12;221(2):325-36.
3. Kajta M, et al. Neuroscience. 2013 May 15;238:345-60.
产品手册
关联产品
-
Elacestrant
Elacestrant (RAD-1901) is a novel, orally bioavailable small-molecule selective estrogen receptor degrader (SERD).
-
Nafoxidine
Nafoxidine is an estrogen antagonist that has been used in the treatment of breast cancer.
-
ARV-471
ARV-471 is a best-in-class, orally active Cereblon -based estrogen receptor ( ER ) PROTAC degrader. ARV-471 is developed for the research of breast cancer.
